Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

3.23%

16.0¢

Market Cap $78.76M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NUZ ANNOUNCES STRONG RESULTS IN LATEST STUDY

Latest Threads

Tag

Subject

NUZ -- New Investor thread

26 27 28

15:33

1.6K

521K

15:33

Last post Captain Goodvybes

1.6K

521K

NUZ Charting Thread

13/06/25

14

4.5K

13/06/25

Last post Boffin99

14

4.5K

TOP 200 NUZ SHAREHOLDERS AS AT 31 MAY 2025

03/06/25

2

1.3K

03/06/25

Last post Quiltman

2

1.3K

Ann: Change of Registered Office and Principal Place of Business

02/06/25

4

1.7K

02/06/25

Last post Dryasachip

4

1.7K

TOP 200 NUZOA HOLDERS 31 MAY 2025

01/06/25

1

803

01/06/25

Last post Captain Goodvybes

1

803

Ann: Monepantel Selected for Entry into HEALEY ALS Platform Trial

2

30/05/25

90

29K

30/05/25

Last post gavros

90

29K

NUZ TOP 100 HOLDERS AS AT 30 APRIL 2025

26/05/25

9

3.9K

26/05/25

Last post adreamer

9

3.9K

Ann: Neurizon to present Q3 FY2025 Results

2

24/05/25

66

19K

24/05/25

Last post Van1

66

19K

Ann: Notice of Quarterly Shareholder Update Webinar

18/05/25

28

9.9K

18/05/25

Last post Boffin99

28

9.9K

Ann: Neurizon to present at Annual ALS Drug Development Summit

17/05/25

19

6.9K

17/05/25

Last post coads

19

6.9K

Ann: Neurizon Commences Initiatives to Lift Clinical Hold

2 3

13/05/25

139

38K

13/05/25

Last post david

139

38K

Archibald Prize Finalist 2025

10/05/25

0

445

10/05/25

Last post Captain Goodvybes

0

445

Ann: Last Patient Successfully Completes Treatment in OLE Study

09/05/25

38

12K

09/05/25

Last post Van1

38

12K

Ann: NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells

2

04/05/25

65

19K

04/05/25

Last post Boffin99

65

19K

NUZOA TOP 100 HOLDERS

01/05/25

0

480

01/05/25

Last post RAN58

0

480

Ann: Appendix 4C & Quarterly Update

29/04/25

35

10K

29/04/25

Last post TheBrownHornet

35

10K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

Change of Registered Office and Principal Place of Business
02 Jun 09:45	Share

Neurizon to present at Annual ALS Drug Development Summit
14 May 16:54	Share

Neurizon to present Q3 FY2025 Results
06 May 12:48	Share

Last Patient Successfully Completes Treatment in OLE Study
05 May 09:23	Share

Appendix 4C & Quarterly Update
28 Apr 09:11	Share

Notice of Quarterly Shareholder Update Webinar
24 Apr 09:28	Share

Appointment of Chief Financial Officer
22 Apr 09:28	Share

Leadership team strengthened with strategic appointments
17 Apr 09:22	Share

NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04 Apr 12:07	Share

NUZ-001 Shows Positive Results in Human 3D Brain Model
01 Apr 09:03	Share

NUZ-001 shows promising respiratory outcome
24 Mar 09:47	Share

Neurizon Commences Initiatives to Lift Clinical Hold
17 Mar 09:22	Share

Appendix 4D - Half-year Financial Report - 31 December 2024
17 Feb 14:28	Share

Neurizon to Present Latest Results and Key Updates
17 Feb 09:27	Share

FDA Guidance on NUZ-001 IND Application
17 Feb 09:14	Share

Notice of Company Update Webinar
11 Feb 14:29	Share

Change of Director's Interest Notices x3
07 Feb 09:58	Share

US Patent granted for NUZ-001
05 Feb 09:18	Share

Notification regarding unquoted securities - NUZ
31 Jan 16:46	Share

Appendix 4C & Quarterly Update
29 Jan 09:14	Share

Neurizon updates on NUZ-001 IND Application
17 Jan 09:59	Share

Change of Share Registry
16 Jan 08:19	Share

Section 708A Cleansing Statement
27 Dec 17:07	Share

Application for quotation of securities - NUZ
27 Dec 17:00	Share

Neurizon Files IND Application to Support HEALEY ALS Trial
18 Dec 09:13	Share

Neurizon Granted OMPD for NUZ-001 in Europe
17 Dec 08:52	Share

Positive 8-month Interim Data from OLE Study
16 Dec 09:34	Share

Neurizon Presents Company Update and 2025 Outlook
12 Dec 15:08	Share

Neurizon Receives Additional R&D Tax Incentive Rebate
11 Dec 13:47	Share

Notice of Company Update Webinar
05 Dec 09:29	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.0¢		Change 0.005(3.23%)		Mkt cap ! $78.76M

Open	High	Low	Value	Volume
15.5¢	16.0¢	15.0¢	$78.77K	503.0K

Buyers (Bids)

No.	Vol.	Price($)
3	240870	15.0¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	377391	2

View Market Depth

No.	Vol.	Price($)
3	240870	0.150
7	1185247	0.145
7	145632	0.140
5	146261	0.135
1	10000	0.125

Price($)	Vol.	No.
0.160	377391	2
0.165	118100	2
0.170	16335	2
0.175	6045	1
0.180	251616	3

Last trade - 16.10pm 13/06/2025 (20 minute delay)

NUZ (ASX) Chart